×
AllNewsImages Maps Videos Books
Search tools

Acceleron Fusion Secures $24M Series A Led by Lowercarbon Capital and Collaborative Fund to Revolutionize Clean Energy with Muon-Catalyzed Fusion

PRWeb
Share this article ... Acceleron Fusion, a pioneer in muon-catalyzed fusion energy, has closed a $24 million Series A funding round. The funding...
6 months ago

Acceleron Banks on Muons for Colder Fusion

IEEE Spectrum
Acceleron Fusionis the latest startup to take a swing at this challenging nuclear-energy technology, banking on a novel approach that uses beams...
6 months ago

Acceleron Announces Partnership With Fiserv to Deliver Seamless Foreign Exchange Services

Newswire :) Press Release Distribution
Acceleron, a high-tech software platform offering a Foreign Exchange (FX) marketplace, is now integrated into Payments Exchange: Foreign Exchange Services from...
7 months ago

Acceleron advances cold fusion technology

Nuclear Engineering International
Acceleron says the funding will support efforts to advance its low-temperature muon-catalysed fusion technology – sometimes described as a form of cold fusion.
6 months ago

Exclusive: Acceleron Fusion has raised $15M to take a stab at colder fusion, filing reveals

TechCrunch
A young startup, Acceleron Fusion, is joining the pack, having raised $15 million of a targeted $23.7 million round, according to an SEC filing.
8 months ago

How a new approach to finance and tax is turbocharging Accelleron

EY
Managed Services is helping Accelleron build a future-fit operating model. Read more in this case study.
4 months ago

US firm's 'cool' plasma-free fusion technology gets funding boost

Interesting Engineering
Acceleron Fusion raises $24M to advance muon-catalyzed fusion, a fusion energy approach that operates at significantly lower temperatures.
6 months ago

Merck preps filings after blockbuster-in-waiting Winrevair succeeds in severe PAH study

Fierce Pharma
Merck's activin signaling inhibitor Winrevair, also known as sotatercept, met its primary endpoint of time to first morbidity or mortality event.
7 months ago

Merck to buy Acceleron for about $11.5 billion in rare-disease drugs push

CNBC
Merck to buy Acceleron for about $11.5 billion in rare-disease drugs push ... Merck is buying Acceleron Pharma for about $11.5 billion, broadening...
44 months ago

Merck’s Acceleron Integration To Take Out 143 Jobs in Cambridge, MA

BioSpace
Merck announced that it will be laying off 143 people from the Cambridge, Massachusetts-based Acceleron. ... In November 2021, Merck completed its...
38 months ago